Torii Pharmaceutical Co., Ltd.
TRXPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $60,425 | $54,638 | $48,894 | $46,987 |
| % Growth | 10.6% | 11.7% | 4.1% | – |
| Cost of Goods Sold | $33,718 | $31,880 | $25,516 | $22,648 |
| Gross Profit | $26,707 | $22,758 | $23,378 | $24,339 |
| % Margin | 44.2% | 41.7% | 47.8% | 51.8% |
| R&D Expenses | $2,824 | $3,490 | $1,661 | $832 |
| G&A Expenses | $2,290 | $2,033 | $1,707 | $0 |
| SG&A Expenses | $4,250 | $3,615 | $3,288 | $4,187 |
| Sales & Mktg Exp. | $1,960 | $1,582 | $1,581 | $4,187 |
| Other Operating Expenses | $12,835 | $10,618 | $12,886 | $14,660 |
| Operating Expenses | $19,909 | $17,723 | $17,835 | $19,679 |
| Operating Income | $6,798 | $5,035 | $5,540 | $4,656 |
| % Margin | 11.3% | 9.2% | 11.3% | 9.9% |
| Other Income/Exp. Net | -$73 | $558 | $182 | $111 |
| Pre-Tax Income | $6,725 | $5,593 | $5,722 | $4,767 |
| Tax Expense | $1,682 | $1,473 | $1,778 | $1,392 |
| Net Income | $5,042 | $4,119 | $3,944 | $3,374 |
| % Margin | 8.3% | 7.5% | 8.1% | 7.2% |
| EPS | 179.46 | 146.57 | 140.38 | 120.11 |
| % Growth | 22.4% | 4.4% | 16.9% | – |
| EPS Diluted | 179.46 | 146.57 | 140.38 | 120.11 |
| Weighted Avg Shares Out | 28 | 28 | 28 | 28 |
| Weighted Avg Shares Out Dil | 28 | 28 | 28 | 28 |
| Supplemental Information | – | – | – | – |
| Interest Income | $357 | $287 | $167 | $144 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $408 | $459 | $252 | $279 |
| EBITDA | $7,133 | $6,052 | $5,975 | $5,047 |
| % Margin | 11.8% | 11.1% | 12.2% | 10.7% |